The Novel Drug Delivery Systems Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Novel Drug Delivery Systems Market?
The size of the novel drug delivery systems market has seen significant growth recently. In 2024, the market size was $106.95 billion and this is expected to increase to $117.66 billion in 2025, representing a compound annual growth rate (CAGR) of 10.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Novel Drug Delivery Systems Industry?
The Novel Drug Delivery Systems Global Market is projected to reach $171.02 billion in 2029, with a compound annual growth rate (CAGR) of 9.8%.
Download Your Free Sample of the 2025 Novel Drug Delivery Systems Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Novel Drug Delivery Systems Market?
The key drivers in the novel drug delivery systems market are:
• Increasing cases of neurological disorders
• Aging populations increasing the prevalence of such disorders
• Rise in lifestyle-related conditions such as hypertension, diabetes, and obesity
• Exposure to chronic stress and environmental risk factors
Global Market Segmentation: Identifying Major Novel Drug Delivery Systems Industry Segments
The novel drug delivery systems market covered in this report is segmented –
1) By Formulation Type: Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers
2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems
3) By Route: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes
4) By Therapeutic Area: Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases
5) By End-User: Hospital, Specialty Clinics, Research Centers, Other End-Users
Pre-order the 2025 Novel Drug Delivery Systems Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Novel Drug Delivery Systems Market?
The key trends in the novel drug delivery systems market are:
• Innovative drug delivery methods, such as oral thin films, are seeing an increasing focus from major market companies.
• There's an increasing preference for delivery systems that can enhance patient adherence and therapeutic efficiency.
• Methods that enable rapid drug absorption, bypassing the gastrointestinal and liver metabolism, are emerging.
• Systems supporting accurate dosing and faster onset of action, improving treatment precision and convenience, are trending.
Who Are the Top Competitors & Leading Players in the Novel Drug Delivery Systems Market?
Major players in the novel drug delivery systems market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi SA
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Company
• AstraZeneca PLC
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline PLC (GSK)
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Gilead Sciences
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Boston Scientific Corporation
• Regeneron Pharmaceuticals
• Samyang Holdings Corporation
• Galen Limited
Regional Dominance: Which Area Leads the Global Novel Drug Delivery Systems Market?
North America was the largest region in the novel drug delivery systems market in 2024
